Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

Main Article Content

Gianpaolo Perletti *
(*) Corresponding Author:
Gianpaolo Perletti |


Not available.

Downloads month by month


Download data is not yet available.

Article Details